CVA Family Office’s Denali Therapeutics DNLI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-30	Closed	-$611	–	1415
2024 Q4	$611	Hold	30	–	–	﹤0.01%	1184
2024 Q3	$874	Hold	30	–	–	﹤0.01%	1091
2024 Q2	$697	Buy	+30	New	+$697	﹤0.01%	1122